FREE Account Opening + No Clearing Fees
Loading...

Antony Waste IPO vs Gland Pharma IPO

Comparision between Antony Waste IPO and Gland Pharma IPO.

IPO Details

Antony Waste IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Gland Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Antony Waste IPO is up to ₹300.00 Cr whereas the issue size of the Gland Pharma IPO is up to ₹6,479.55 Cr. The final issue price of Antony Waste IPO is ₹315.00 per share and of Gland Pharma IPO is ₹1,500.00 per share.

  Antony Waste IPO Gland Pharma IPO
Face Value ₹5 per share ₹1 per share
Issue Price (Lower) ₹313.00 per share ₹1,490.00 per share
Issue Price (Upper) ₹315.00 per share ₹1,500.00 per share
Issue Price (Final) ₹315.00 per share ₹1,500.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 47 shares 10 shares
Fresh Issue Size 26,98,412 shares 83,33,333 shares
Fresh Issue Size (Amount) up to ₹85.00 Cr up to ₹1,250.00 Cr
OFS Issue Size 68,24,933 shares 3,48,63,635 shares
OFS Issue Size (Amount) up to ₹215.00 Cr up to ₹5,229.55 Cr
Issue Size Total 95,23,345 shares 4,31,96,968 shares
Issue Size Total (Amount) up to ₹300.00 Cr up to ₹6,479.55 Cr

IPO Timetable

Antony Waste IPO opens on Dec 21, 2020, while Gland Pharma IPO opens on Nov 09, 2020. The closing date of Antony Waste IPO and Gland Pharma IPO is Dec 23, 2020, and Nov 11, 2020, respectively.

  Antony Waste IPO Gland Pharma IPO
Anchor Bid Date
Issue Open Dec 21, 2020 Nov 09, 2020
Issue Close Dec 23, 2020 Nov 11, 2020
Basis Of Allotment (Tentative) Dec 29, 2020 Nov 17, 2020
Initiation of Refunds (Tentative) Dec 30, 2020 Nov 18, 2020
Credit of Share (Tentative) Dec 31, 2020 Nov 19, 2020
Listing date (Tentative) Jan 01, 2021 Nov 20, 2020
Anchor Lockin End date 1 Jan 28, 2021 Dec 17, 2020
Anchor Lockin End date 2 Mar 29, 2021 Feb 15, 2021

Financials

Antony Waste IPO P/E ratio is , as compared to Gland Pharma IPO P/E ratio of .

  Antony Waste IPO Gland Pharma IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
30-Sept-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 7,075.67 6,721.03 5,126.38 4,280.70
Total Revenue 2,151.01 4,646.11 2,985.18 2,907.78
Profit After Tax 290.50 620.76 346.82 398.84
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
30-June-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 46,912.65 40,860.39 35,235.49 29,294.68
Total Revenue 9,162.89 27,724.08 21,297.67 16,716.82
Profit After Tax 3,135.90 7,728.58 4,518.56 3,210.51
Promoter Shareholding (Pre-Issue) 51.10% 74%
Promoter Shareholding (Post-Issue) 46.20% 58%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Antony Waste IPO retail investors (RII) are offered 33,33,171 shares while in Gland Pharma IPO retail investors are offered 33,33,171 shares. Qualified institutional buyers (QIB) are offered 19,04,669 shares in Antony Waste IPO and 86,39,394 shares in Gland Pharma IPO.

  Antony Waste IPO Gland Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 19,04,669 shares 86,39,394 shares
NII 14,28,502 shares 64,79,546 shares
RII 33,33,171 shares 1,51,18,939 shares
Employee 0 shares 0 shares
Others
Total 66,66,342 shares 3,02,37,879 shares

Bids Received (Subscription)

Antony Waste IPO subscribed 15.04x in total, whereas Gland Pharma IPO subscribed 2.06x.

  Antony Waste IPO Gland Pharma IPO
QIB (times) 9.67x 6.40x
NII (times) 18.69x 0.51x
Big NII (times)
Small NII (times)
RII (times) 16.55x 0.24x
Employee (times)
Other (times)
Total (times) 15.04x 2.06x

Comments

Add a public comment...